These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7135387)

  • 21. Human serum paraoxonase is inhibited in EDTA plasma.
    Mackness MI
    Biochem Biophys Res Commun; 1998 Jan; 242(2):249. PubMed ID: 9446778
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of Globular Plasma Proteins with Water-Soluble CdSe Quantum Dots.
    Pathak J; Rawat K; Sanwlani S; Bohidar HB
    Chemphyschem; 2015 Jun; 16(8):1777-86. PubMed ID: 25767054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of chelating agents on the excretion of cadmium in cadmium poisoning].
    Eybl V; Sýkora J; Mertl F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Nov; 252(1):85-93. PubMed ID: 4222726
    [No Abstract]   [Full Text] [Related]  

  • 24. [A new method for determination of cadmium in plasma (author's transl)].
    Raptis S; Müller K
    Clin Chim Acta; 1978 Sep; 88(2):393-402. PubMed ID: 29728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro toxicokinetic studies of cyclosarin: molecular mechanisms of elimination.
    Reiter G; Müller S; Koller M; Thiermann H; Worek F
    Toxicol Lett; 2014 May; 227(1):1-11. PubMed ID: 24641973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dithiocarbamates and cadmium metabolism: further correlations of cadmium chelate partition coefficients with pharmacologic activity.
    Gale GR; Atkins LM; Walker EM; Smith AB; Jones MM
    Ann Clin Lab Sci; 1984; 14(2):137-45. PubMed ID: 6324647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biliary excretion of cadmium in rat. VI. Mobilization of cadmium from metallothionein by 2,3-dimercaptopropanol.
    Cherian MG
    J Toxicol Environ Health; 1980 Mar; 6(2):393-401. PubMed ID: 7392100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-protein interaction: plasma protein binding of furocoumarins.
    Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G
    Farmaco Sci; 1979 Aug; 34(8):716-25. PubMed ID: 467637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluation of potential aluminum chelators.
    Graff L; Muller G; Burnel D
    Vet Hum Toxicol; 1995 Oct; 37(5):455-61. PubMed ID: 8592836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of the binding parameters of drug to protein by equilibrium dialysis/piezoelectric quartz crystal sensor.
    Zhou A; He D; Nie LH; Yao SZ
    Anal Biochem; 2000 Jun; 282(1):10-5. PubMed ID: 10860493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of plasma proteins on delayed repolarization in vitro with cisapride, risperidone, and D, L-sotalol.
    Limberis JT; McDermott JS; Salmen HJ; Su Z; Mikhail A; Green JR; Cox BF; Gintant GA; Martin RL
    J Pharmacol Toxicol Methods; 2007; 56(1):11-7. PubMed ID: 17350293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonists for acute oral cadmium chloride intoxication.
    Basinger MA; Jones MM; Holscher MA; Vaughn WK
    J Toxicol Environ Health; 1988; 23(1):77-89. PubMed ID: 2826797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
    Behm HL; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR identification of endogenous metabolites interacting with fatted and non-fatted human serum albumin in blood plasma: Fatty acids influence the HSA-metabolite interaction.
    Jupin M; Michiels PJ; Girard FC; Spraul M; Wijmenga SS
    J Magn Reson; 2013 Mar; 228():81-94. PubMed ID: 23357430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides.
    Maiorino RM; Xu ZF; Aposhian HV
    J Pharmacol Exp Ther; 1996 Apr; 277(1):375-84. PubMed ID: 8613944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport of conjugates of toxicants by blood proteins.
    Shah PV; Helling DJ; Maliwal BP; Guthrie FE
    Toxicol Lett; 1985; 24(2-3):215-20. PubMed ID: 3983972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo depression of reserve albumin binding capacity by cadmium: a preliminary evaluation.
    Roberts CA; Clark JM
    Life Sci; 1988; 42(14):1369-73. PubMed ID: 3352458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.